Clario has obtained 510(k) clearance from the US Food and Drug Administration (FDA) for its SpiroSphere with the integrated wireless COR-12 electrocardiogram (ECG) device. The clearance enables the ...
With the FDA 510(k) clearance of the COR-12 wireless ECG device now integrated with the SpiroSphere®, sponsors can conduct comprehensive respiratory trials with cardiac safety ECG collection on one ...
Clario, a leading provider of technologies and endpoint data solutions for clinical trials, announced the US Food and Drug Administration (FDA) 510(k) clearance for its SpiroSphere with the wireless ...
With the FDA 510(k) clearance of the COR-12 wireless ECG device now integrated with the SpiroSphere®, sponsors can conduct comprehensive respiratory trials with cardiac safety ECG collection on one ...